maprotiline has been researched along with citalopram in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (21.43) | 18.7374 |
| 1990's | 8 (19.05) | 18.2507 |
| 2000's | 15 (35.71) | 29.6817 |
| 2010's | 10 (23.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Faller, B; Trunzer, M; Zimmerlin, A | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Maj, J; Rogóz, Z; Skuza, G; Sowińska, H | 2 |
| Benkelfat, C; Galinowski, A; Lôo, H; Poirier, MF; Sechter, D; Suzini de Luca, H; Vanelle, JM | 1 |
| Campbell, IC; Ellison, DW | 1 |
| Cohen Stuart, MH; de Beurs, P; Høpfner Petersen, HE; Leijnse-Ybema, H; Sanchez, C; Tan, BK; Timmerman, L | 1 |
| Nowak, G; Pawłowski, L | 1 |
| Ostrow, D | 1 |
| de Beurs, P; Leijnse-Ybema, HJ; Møller, SE; Petersen, HE; Stuart, MH; Tan, BK; Timmerman, L | 1 |
| Bouchard, JM; Delaunay, J; Delisle, JP; Grasset, N; Mermberg, PF; Molczadzki, M; Pagot, R; Richou, H; Robert, G; Ropert, R | 1 |
| Benkelfat, C; Gay, C; Léouffre, P; Löo, H; Poirier, MF | 1 |
| Golden, RN; Potter, WZ; Rudorfer, MV | 1 |
| al-Tikriti, MS; Baldwin, RM; Laruelle, M; Malison, RT; Neumeyer, JL; Sybirska, EH; Wisniewski, G; Zea-Ponce, Y; Zimmermann, RC; Zoghbi, SS | 1 |
| Klimek, V; Mackowiak, M; Zak-Knapik, J | 1 |
| Hashimoto, S; Inoue, T; Koyama, T | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Dziedzicka-Wasylewska, M; Klimek, V; Maj, J; Rogoz, R | 1 |
| Besnard, JC; Bottlaender, M; Chalon, S; Coulon, C; Emond, P; Frangin, Y; Fuseau, C; Guenther, I; Guilloteau, D; Helfenbein, J; Loc'h, C; Maziere, B; Ottaviani, M | 1 |
| Barak, Y; Kimhi, R; Weizman, R | 1 |
| Beraus, W; Conca, A; Fritzsche, H; König, P; Peschina, W | 1 |
| Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Wilson, AA | 1 |
| Conca, A; Hubmann, MR; König, P; Moll, W; Waschgler, R | 1 |
| Arai, S; Dohi, T; Kihira, K; Kitayama, S; Kumagai, K; Kumagai, M; Morita, K | 1 |
| Feltenstein, MW; Sufka, KJ | 1 |
| Amelin, AV; Ignatov, IuD; Miatleva, MI; Skoromets, AA; Tarasova, SV | 1 |
| Pettersen, VL; Raimundo, JM; Sudo, RT; Trachez, MM; Zapata-Sudo, G | 1 |
| Ide, S; Minami, M; Satoh, M; Satoyoshi, H | 1 |
2 review(s) available for maprotiline and citalopram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
8 trial(s) available for maprotiline and citalopram
| Article | Year |
|---|---|
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patients.
Topics: Adult; Aged; Bipolar Disorder; Citalopram; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Serotonin Antagonists; Thyrotropin; Thyrotropin-Releasing Hormone | 1990 |
A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Topics: Adult; Aged; Anthracenes; Blood Platelets; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dexamethasone; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Propylamines; Serotonin | 1987 |
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
Topics: Adult; Aged; Amino Acids; Anthracenes; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Humans; Maprotiline; Middle Aged; Propylamines; Prospective Studies; Psychiatric Status Rating Scales; Tryptophan; Tyrosine | 1986 |
Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.
Topics: Adult; Aged; Anthracenes; Citalopram; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Propylamines; Time Factors | 1987 |
Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression.
Topics: Adult; Aged; Anthracenes; Citalopram; Depressive Disorder; Dexamethasone; Female; Humans; Male; Maprotiline; Middle Aged; Piperidines; Propylamines | 1987 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients?
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Mianserin; Middle Aged; Product Surveillance, Postmarketing; Risk Factors; Selective Serotonin Reuptake Inhibitors | 2000 |
33 other study(ies) available for maprotiline and citalopram
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation.
Topics: Chromatography, Liquid; Drug Design; Humans; Likelihood Functions; Microsomes, Liver; Pharmacokinetics; Tandem Mass Spectrometry | 2009 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
Topics: Animals; Antidepressive Agents; Benzazepines; Citalopram; Dizocilpine Maleate; Fluoxetine; Imipramine; Isomerism; Male; Maprotiline; Motor Activity; Prazosin; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures; Sulpiride | 1992 |
Studies on the role of alpha 2-adrenoceptors in the control of synaptosomal [3H]5-hydroxytryptamine release: effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzylamines; Cerebral Cortex; Citalopram; Clonidine; Clorgyline; Desipramine; Hydroxyindoleacetic Acid; Male; Maprotiline; Nomifensine; Potassium; Propylamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Serotonin; Synaptosomes; Yohimbine | 1986 |
Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram.
Topics: Animals; Apomorphine; Body Temperature; Brain; Citalopram; Desipramine; Male; Maprotiline; Mice; Monoamine Oxidase Inhibitors; Norepinephrine; Piperidines; Propylamines; Reserpine; Serotonin Antagonists; Thyrotropin-Releasing Hormone; Tyramine | 1987 |
The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
Topics: Animals; Apomorphine; Body Temperature; Citalopram; Desipramine; Fluoxetine; Male; Maprotiline; Mice; Norepinephrine; Propylamines; Reserpine; Serotonin Antagonists | 1983 |
SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
Topics: Animals; Brain; Brain Chemistry; Carrier Proteins; Chlorocebus aethiops; Citalopram; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Indans; Iodine Radioisotopes; Levodopa; Ligands; Maprotiline; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Papio; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon | 1993 |
Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
Topics: Animals; Antidepressive Agents; Binding Sites; Brain; Citalopram; Fluoxetine; Ketanserin; Male; Maprotiline; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin | 1994 |
Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats.
Topics: Animals; Behavior, Animal; Citalopram; Dose-Response Relationship, Drug; Fear; Fluvoxamine; Male; Maprotiline; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 1996 |
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Desipramine; Drug Interactions; Fluoxetine; Fluvoxamine; Imipramine; Ketanserin; Male; Maprotiline; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 1997 |
Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Citalopram; Imipramine; Male; Maprotiline; Norepinephrine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Selective Serotonin Reuptake Inhibitors | 1997 |
A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experiments.
Topics: Animals; Brain; Bromine Radioisotopes; Cerebellum; Cerebral Cortex; Citalopram; Cocaine; Corpus Striatum; Dopamine; Kinetics; Male; Maprotiline; Nortropanes; Papio; Piperazines; Radiopharmaceuticals; Rats; Rats, Wistar; Thalamus; Tissue Distribution; Tomography, Emission-Computed | 1999 |
Low frequency rTMS as an add-on antidepressive strategy: heterogeneous impact on 99mTc-HMPAO and 18 F-FDG uptake as measured simultaneously with the double isotope SPECT technique. Pilot study.
Topics: Adult; Antidepressive Agents; Brain; Brain Mapping; Citalopram; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetics; Male; Maprotiline; Pilot Projects; Radiopharmaceuticals; Reference Values; Technetium Tc 99m Exametazime; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Trazodone | 2001 |
[11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
Topics: Adrenergic Uptake Inhibitors; Animals; Benzylamines; Brain; Carrier Proteins; Cats; Citalopram; Dopamine Antagonists; Fluoxetine; Haloperidol; Maprotiline; Membrane Glycoproteins; Membrane Transport Proteins; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Tranylcypromine | 2003 |
Simultaneous quantification of citalopram, clozapine, fluoxetine, norfluoxetine, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC analysis.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chromatography, High Pressure Liquid; Citalopram; Clozapine; Fluoxetine; Humans; Maprotiline; Trazodone | 2002 |
Chronic inhibition of the norepinephrine transporter in the brain participates in seizure sensitization to cocaine and local anesthetics.
Topics: Adrenergic Uptake Inhibitors; Anesthetics, Local; Animals; Brain; Brain Chemistry; Citalopram; Cocaine; Desipramine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Lidocaine; Male; Maprotiline; Mice; Mice, Inbred ICR; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Seizures; Selective Serotonin Reuptake Inhibitors; Symporters; Time Factors | 2003 |
Screening antidepressants in the chick separation-stress paradigm.
Topics: Animals; Antidepressive Agents; Anxiety, Separation; Chickens; Citalopram; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Imipramine; Maprotiline; Phenelzine; Sleep Wake Disorders; Stress, Psychological | 2005 |
[Antidepressants with different action mechanisms in the treatment of chronic daily headache].
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Citalopram; Cyclopropanes; Diagnosis, Differential; Female; Follow-Up Studies; Headache; Humans; Male; Maprotiline; Middle Aged; Milnacipran; Pain Measurement; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2007 |
The synergistic interaction between morphine and maprotiline after intrathecal injection in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Injections, Spinal; Male; Maprotiline; Morphine; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Wistar; Reaction Time; Selective Serotonin Reuptake Inhibitors; Time Factors; Yohimbine | 2009 |
Amelioration of the reduced antinociceptive effect of morphine in the unpredictable chronic mild stress model mice by noradrenalin but not serotonin reuptake inhibitors.
Topics: Analgesics; Animals; Chronic Disease; Citalopram; Disease Models, Animal; Male; Maprotiline; Mice, Inbred BALB C; Morphine; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Stress, Physiological; Temperature; Tramadol | 2015 |